Effects of ezetimibe added to ongoing statin therapy on C-reactive protein levels in hypercholesterolemic patients.

1 ), the control (r=-0.55, p=0.000), and the statin groups (r=-0.60, p=0.000), and in the ezetimibe group with borderline significance (r=-0.22, p=0.09).

also in 7,017 other papers

In another study, the addition of ezetimibe to patients taking statins decreased CRP levels in Caucasian patients but not in African and Hispanic patients, although the difference did not reach statistical significance.

also in 111,027 other papers